Following the Analyst Projections for Magellan Health, Inc. (NASDAQ:MGLN)

November 28, 2017

Wall Street analysts have the ability to provide stock ratings for companies that they track. Based on analysts used by Zacks Research, the present average broker rating on shares of Magellan Health, Inc. (NASDAQ:MGLN) is currently 2.6. This mean rating includes analysts who have offered Sell, Buy and Hold ratings on the equity. This rating lands on a numerical recommendation scale from 1 to 5. A score of 1 would represent a Buy recommendation, and a score of 5 would indicate a Sell recommendation. Out of all the analysts providing ratings, 2 have rated the stock a Strong Buy or Buy, based on data provided by Zacks Research. 

Many investors may have noticed that when the stock market has been running bullishly hot for quite some time, market tops can be a very busy place. Trading interest may be noticeably higher when the good times are rolling. This can be tricky because often times, prices may become inflated and somewhat overvalued. Traders will need to pay much more attention to what is going on at the tops of these bull runs. When interest is heightened, traders who got in at much better prices may be looking to unload the winners for quick profits. Doing the proper research can help clear out some of the fog that comes with an oversaturated market. Chartists will most likely be paying attention to price moves and trying to spot the next series of trends that develop. Spotting a trend earlier than the crowd may help the trader sell before the big drop or buy before the big rise. Learning how opportunities unfold and present themselves in the stock market may take a lot of time and effort to master. Professional traders are typically a few moves ahead of the novice and relatively naive trader. Getting to that next level should be on the mind of any dedicated trader or investor. Learning from past mistakes can make a huge difference in the future of the trader’s profits and psyche.

Zooming in on recent stock price action for Magellan Health, Inc. (NASDAQ:MGLN), we note that shares are trading near the 83.35 level. Investors will often follow stock price levels in relation to the 52-week high and low levels. The 52-week high is presently 88, and the 52-week low is sitting at 64.63. When a stock price is getting close to either the 52-week high or 52-week low, investors may track activity to watch for a move past the established mark. Over the last 12 weeks, shares have seen a change of 3.03%. Heading further back to the start of the year, we note that shares have seen a change of 10.76%. Focusing in closer to the last 4 weeks, shares have seen a change of -1.59%. Over the past five trading days, the stock has changed 0.97%.

Sell-side Wall Street analysts will commonly offer stock price target estimates. Many investors pay close attention to where the analysts project the stock moving in the future. After a recent scan, we can see that analysts polled by Zacks Research have set a consensus price target of $91 on shares of Magellan Health, Inc. (NASDAQ:MGLN). Price target estimates can be calculated using various methods, and they may be quite different depending on the individual analyst. A fully researched analyst report will generally provide detailed reasoning for a specific target price prediction. Some investors may track analyst targets very closely and use the information to complement their own stock research.

Taking a quick look at the current quarter EPS consensus estimate for Magellan Health, Inc. (NASDAQ:MGLN), we can see that the most recent level is sitting at 2.3. This EPS projection uses 3 Sell-Side analysts polled by Zacks Research. For the previous reported quarter, the company posted a quarterly EPS of 1.64. Covering analysts have the tough job of following companies and offering future estimates. These estimates are often closely followed on the Street, and earnings beats or misses revolve around these projections. Sometimes these predictions are extremely close to the actual reported number, and other times they may be way off. When a company posts actual earnings numbers, the surprise factor can lead to sudden stock price fluctuations. If a company meets and beats estimates and posts a positive earnings surprise, the stock may see a near-term bump. On the other end, a negative surprise may send the stock in the opposite direction. Many investors will choose to trade with caution around earnings releases and wait to make a move until after the major activity has subsided.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

By DR Staff Writer

Free Email Newsletter


Enter your email address below to get the latest news and analysts' ratings for your stocks with MarketBeat's FREE daily email newsletter:


Latest Stories